|
Inter-Agency Working Group on Technology Transfer
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
OD/OIR/OTT, OD/OER
|
This working group recommends opportunities for improving technology transfer (TT) from Federal laboratories, including: (i) current technology transfer programs and standards for assessing the effectiveness of these programs; (ii) new or creative approaches to technology transfer that might serve as model programs for Federal laboratories; (iii) criteria to assess the effectiveness and impact on the Nation''s economy of planned or future technology transfer efforts; (iv) an assessment of cooperative research and development venture programs; and (v) policy and guidance statements to support all Federal Agencies'' TT programs.
|
|
Inter-Society Coordinating Committee (ISCC) for Practitioner Education in Genomics
|
Committee, Work group, Advisory group, or Task Force
|
CMS, HRSA
|
NHGRI, NCI, NEI, NHLBI, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIGMS, NIMH, NINDS, NINR, NLM
|
This education collaborative facilitates sharing interactions among professional societies, agencies, and health systems. It intends to enhance the accrual of knowledge and skill among practitioners applying genomic results to clinical care. In its start-up phase, the ISCC focused primarily on physicians and dentists. It has since expanded to engage and collaborate with allied practitioner groups such as nurse practitioners, physician assistants, pharmacists, genetic counselors, and nurses comprising integrated health care teams. It will continue to add other relevant professions and add to the reviewed and searchable educational resources on its website.
|
|
Interactive Publications
|
Resource Development
|
CDC
|
NLM
|
NLM collaborated with the CDC National Center for Health Statistics to convert the CDC''s "Health US in Brief" to interactive form, which can be viewed using NLM''s Panorama software. In addition, another important document was converted to interactive form--a Data Brief called Death in the United States. Interactive Publications are scientific multimedia documents that give readers more information from an article than is available in the published form (electronic or print) by enabling interaction with the included media (tables, graphs, images, videos, biomedical image studies, etc.). NLM conducts research into models for highly interactive multimedia documents that could transform the next generation of publishing in biomedicine. We focus on the standards, formats, authoring and reading tools necessary for the creation and use of such interactive publications that, in addition to text, contain media objects relevant to biomedical research and clinical practice: video, audio, bitmapped images, interactive tables and graphs, and clinical digital imaging and communications in medicine (DICOM) images such as x-rays, CT, MRI, and ultrasound.
|
|
Interagency Agreement for Communications on Prevention of Underage Tobacco Use
|
Public Education Campaign
|
FDA
|
NCI
|
The FDA Center for Tobacco Products (CTP) and the NCI Office of Communications and Education are collaborating on an Interagency Agreement in which CTP will provide funds to NCI to provide planning, formative research, target messaging, creative content, outreach strategies, and communications support for a campaign to prevent underage tobacco use as it relates to FDA’s authorities under the Tobacco Control Act. Primary focus areas include multi-ethnic journalist training and outreach; development of a partnership strategy, digital strategy, and social marketing tools; digital gaming best practices; and formation of a CTP communications workgroup comprised of subject matter experts.
|
|
Interagency Artificial Pancreas Working Group
|
Other
|
FDA
|
NIDDK, NIBIB, NICHD
|
The Interagency Artificial Pancreas Working Group is a group of multi-disciplined scientists and clinicians from the Food and Drug Administration (FDA) and the NIH to support the Artificial Pancreas Initiative. The goals of this initiative are to provide infrastructure for narrowing the gap between basic biomedical knowledge and clinical application of novel technologies, and to cross-fertilize and partner with stakeholders in order to identify and overcome the clinical and scientific challenges to the development of an artificial pancreas. Through collaborative efforts, such as workshops, the group strives to develop innovative strategies to achieve their goals.
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, CDC, CMS, FDA, HRSA, SAMHSA
|
NIMH, NICHD, NIDCD, NIEHS, NINDS
|
In accordance with the Combating Autism Act of 2006 (CAA) and the Combating Autism Reauthorization Act of 2011 (CARA), the Interagency Autism Coordinating Committee (IACC), a federal advisory committee, is charged with coordinating all efforts with the Department of Health and Human Services concerning autism spectrum disorder (ASD). The committee was established in an effort to accelerate progress in autism spectrum disorder (ASD) biomedical and services research by improving coordination and communication across the Federal government and by working in partnership with the autism community. The committee is composed of officials from many different federal agencies involved in autism research and services, as well as members with ASD, parents, advocates, researchers and other members of the autism community. Member agencies include NIH, CDC, FDA, CMS, ACL, ACF and HRSA within HHS, Department of Education and Department of Defense. In accordance with the CAA and CARA, the committee is charged with providing advice to the Secretary of Health and Human Services regarding activities and issues related to ASD. The IACC is also tasked with developing and annually updating a strategic plan for ASD research, monitoring federal activities related to autism, and preparing an annual summary of advances in ASD research.
|
|
Interagency Chemical Hazards Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NINDS
|
Working group on chemical hazards led by the Office of Science and Technology Policy (OSTP).
|
|
Interagency Chemical Risk Assessment Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NINDS, NIAID
|
Department of Homeland Security led effort to determine chemical hazards and develop Chemical Risk Threat Assessment list of priority chemicals.
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDCD
|
A Government-wide group, the Interagency Committee on Disability Research (ICDR), meets monthly to discuss the issues related to identifying people with disabilities and coordinate research in this area.
|
|
Interagency Committee on Emergency Medical Services for Children Research (ICER)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, OS, SAMHSA
|
NICHD, NIAID, NIAMS, NIDCR, NIGMS, NIMH, NINR
|
ICER is a federal collaborative effort begun in the mid-1990’s to improve the quality and quantity of Emergency Medical Services for Children (EMSC) research, to foster collaboration between federal agencies in highlighting EMSC research topics during development of research agendas, and to reduce barriers to the production of high quality EMSC research.
|